These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8148235)

  • 1. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view.
    Streilein JW
    Reg Immunol; 1993; 5(5):253-68. PubMed ID: 8148235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral tolerance induction: lessons from immune privileged sites and tissues.
    Streilein JW
    Transplant Proc; 1996 Aug; 28(4):2066-70. PubMed ID: 8769158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Privilege revisited: an evaluation of the eye's defence mechanisms.
    Forrester JV
    Eye (Lond); 2009 Apr; 23(4):756-66. PubMed ID: 18989350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.
    Streilein JW; Takeuchi M; Taylor AW
    Hum Immunol; 1997 Feb; 52(2):138-43. PubMed ID: 9077562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ocular immune responses.
    Streilein JW
    Eye (Lond); 1997; 11 ( Pt 2)():171-5. PubMed ID: 9349408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.
    Mrass P; Weninger W
    Immunol Rev; 2006 Oct; 213():195-212. PubMed ID: 16972905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune deviation in relation to ocular immune privilege.
    Streilein JW; Ksander BR; Taylor AW
    J Immunol; 1997 Apr; 158(8):3557-60. PubMed ID: 9103414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A privileged view of NKT cells and peripheral tolerance through the eye.
    Stein-Streilein J
    Ocul Immunol Inflamm; 2005; 13(2-3):111-7. PubMed ID: 16019670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The testis in immune privilege.
    Fijak M; Meinhardt A
    Immunol Rev; 2006 Oct; 213():66-81. PubMed ID: 16972897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular autoimmunity: the price of privilege?
    Caspi RR
    Immunol Rev; 2006 Oct; 213():23-35. PubMed ID: 16972894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune regulation and the eye.
    Stein-Streilein J
    Trends Immunol; 2008 Nov; 29(11):548-54. PubMed ID: 18838303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments.
    Streilein JW
    Curr Opin Immunol; 1993 Jun; 5(3):428-32. PubMed ID: 8347303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vision of cell death: Fas ligand and immune privilege 10 years later.
    Ferguson TA; Griffith TS
    Immunol Rev; 2006 Oct; 213():228-38. PubMed ID: 16972907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of regional lymph nodes for mucosal tolerance.
    Kraal G; Samsom JN; Mebius RE
    Immunol Rev; 2006 Oct; 213():119-30. PubMed ID: 16972900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A historical perspective on immunological privilege.
    Simpson E
    Immunol Rev; 2006 Oct; 213():12-22. PubMed ID: 16972893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprotective sertoli cells: making allogeneic and xenogeneic transplantation feasible.
    Mital P; Kaur G; Dufour JM
    Reproduction; 2010 Mar; 139(3):495-504. PubMed ID: 19995832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.